Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C28H28N4O |
| Molecular Weight | 436.5481 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1NC2=C(C=CC=C2)N1C3CCN(CCC(C#N)(C4=CC=CC=C4)C5=CC=CC=C5)CC3
InChI
InChIKey=PHOZZEGHYJVRDX-UHFFFAOYSA-N
InChI=1S/C28H28N4O/c29-21-28(22-9-3-1-4-10-22,23-11-5-2-6-12-23)17-20-31-18-15-24(16-19-31)32-26-14-8-7-13-25(26)30-27(32)33/h1-14,24H,15-20H2,(H,30,33)
| Molecular Formula | C28H28N4O |
| Molecular Weight | 436.5481 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:09:47 GMT 2025
by
admin
on
Mon Mar 31 23:09:47 GMT 2025
|
| Record UNII |
UMD9OSD01W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
281-236-3
Created by
admin on Mon Mar 31 23:09:47 GMT 2025 , Edited by admin on Mon Mar 31 23:09:47 GMT 2025
|
PRIMARY | |||
|
UMD9OSD01W
Created by
admin on Mon Mar 31 23:09:47 GMT 2025 , Edited by admin on Mon Mar 31 23:09:47 GMT 2025
|
PRIMARY | |||
|
3086173
Created by
admin on Mon Mar 31 23:09:47 GMT 2025 , Edited by admin on Mon Mar 31 23:09:47 GMT 2025
|
PRIMARY | |||
|
DTXSID70232790
Created by
admin on Mon Mar 31 23:09:47 GMT 2025 , Edited by admin on Mon Mar 31 23:09:47 GMT 2025
|
PRIMARY | |||
|
83898-28-6
Created by
admin on Mon Mar 31 23:09:47 GMT 2025 , Edited by admin on Mon Mar 31 23:09:47 GMT 2025
|
PRIMARY | |||
|
DESPROPIONYLBEZITRAMIDE
Created by
admin on Mon Mar 31 23:09:47 GMT 2025 , Edited by admin on Mon Mar 31 23:09:47 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
METABOLITE ACTIVE -> PRODRUG | |||
|
PRODRUG -> METABOLITE ACTIVE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
From DrugBank on the parent compound: Bezitramide acts in the body to relieve pain with a potency 20 times that of methadone. Its duration of action is relatively long, lasting up to 12 hours post oral administration, after the achievement of steady state. Its onset of action is slow, with a peak in analgesic effect noted between 2.5-3.5 hours after dosing. It is noted to illicit a strong antitussive effect, which could be of benefit to patients with bronchial carcinoma.
|
